FindTrial
Sign In

An observational study to know the occurrence and actions taken for Adverse drug reactions in patients admitted for treatment in a multispecialty hospital.

An observational analysis of prevalence of adverse drug reaction in a tertiary care multispecialty hospital. - NA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/12/078569
Enrollment
500
Registered
2024-12-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z488- Encounter for other specified postprocedural aftercare Health Condition 2: R50-R69- General symptoms and signs

Interventions

Intervention1: NA: NA Control Intervention1: NA: NA

Sponsors

Indus international hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient hospitalized at IIH for treatment under: Surgical ward Oncology ward Executive ward FICU Private ward Medical ward.

Exclusion criteria

Exclusion criteria: Patient below 18 HIV Patient and leprosy LAMA cases Medico legal cases.

Design outcomes

Primary

MeasureTime frame
Occurrence of adverse drug reaction at each phase of medication cycle.Timepoint: At discharge.—

Secondary

MeasureTime frame
Awareness of Adverse drug reaction in each phase of medication use cycle.Timepoint: Post discharge.—

Countries

India

Contacts

Public ContactDharmender Singh Lather

Indus International Hospital

msiih@indushospitals.com8872735888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026